Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03288142 · ClinicalTrials.gov registry record · NA
The Smart Hypertension Control Study
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 333
- Enrollment target
NCT03288142 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 333 participants.
The verdict
NCT03288142, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 333 participants
- Enrollment target
Study Summary
Investigators at Northwestern University will partner with Omron Healthcare Co., Ltd. (hereinafter referred to as "Omron") to conduct a randomized controlled trial of a hypertension personal control program (HPCP), known as Lark HTN Pro with a home blood pressure monitoring device (HBMD) compared to a HBMD alone. The overarching goal of this study is to investigate the effects of the HPCP on blood pressure, blood pressure self-management behaviors, and healthy lifestyle behaviors among adults with hypertension.
Interventions
- OTHER Hypertension Coaching Application and Home Monitor
- OTHER Control: Tracking Application and Home Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03288142
The ClinicalTrials.gov registry entry for NCT03288142 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypertension Coaching Application and Home Monitor is the first listed.
NCT03288142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03288142 about?
NCT03288142 is a clinical study titled "The Smart Hypertension Control Study". Investigators at Northwestern University will partner with Omron Healthcare Co., Ltd. (hereinafter referred to as "Omron") to conduct a randomized controlled trial of a hypertension personal control program (HPCP), known as Lark HTN Pro with a home blood pressure monitoring device (HBMD) compared to...
What is the current status of trial NCT03288142?
This trial is currently completed. It is a NA study. The enrollment target is 333 participants. The study started on 2017-09-21. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03288142?
The interventions under investigation include: Hypertension Coaching Application and Home Monitor (OTHER), Control: Tracking Application and Home Monitor (OTHER).
Who is sponsoring clinical trial NCT03288142?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.